Ailen Gala Hvozda Arana

Dr. Ailen Gala Hvozda Arana


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LMLidia Maeso
Lidia Maeso
PAPablo Edmundo Antezana
Pablo Edmundo Antezana
AAAilen Gala Hvozda Arana
Ailen Gala Hvozda Arana
PEPablo A. Evelson
Pablo A. Evelson
GOGorka Orive
Gorka Orive
Martin DesimoneMartin Desimone
Martin Desimone
The skin is the largest organ of the body, and it acts as a protective barrier against external factors. Chronic wounds affect millions of people worldwide and are associated with significant morbidity and reduced quality of life. One of the main factors involved in delayed wound healing is oxidative injury, which is triggered by the overproduction of reactive oxygen species. Oxidative stress has been implicated in the pathogenesis of chronic wounds, where it is known to impair wound healing by causing damage to cellular components, delaying the inflammatory phase of healing, and inhibiting the formation of new blood vessels. Thereby, the treatment of chronic wounds requires a multidisciplinary approach that addresses the underlying causes of the wound, provides optimal wound care, and promotes wound healing. Among the promising approaches to taking care of chronic wounds, antioxidants are gaining interest since they offer multiple benefits related to skin health. Therefore, in this review, we will highlight the latest advances in the use of natural polymers with antioxidants to generate tissue regeneration microenvironments for skin wound healing.

1 November 2020 in Experimental Eye Research
Verified
Journal Article
Closed access
AAAilen Gala Hvozda Arana
Ailen Gala Hvozda Arana
RVRomina Mayra Lasagni Vitar
Romina Mayra Lasagni Vitar
CRClaudia G. Reides
Claudia G. Reides
SLS. Fabian Lerner
S. Fabian Lerner
SFSandra Ferrer
Sandra Ferrer

1 April 2021 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
AAAilen Gala Hvozda Arana
Ailen Gala Hvozda Arana
RVRomina M. Lasagni Vitar
Romina M. Lasagni Vitar
CRClaudia G. Reides
Claudia G. Reides
VCValeria Calabró
Valeria Calabró
TMTimoteo Marchini
Timoteo Marchini
SFSandra Ferrer
Sandra Ferrer

18 May 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
PAPablo Edmundo Antezana
Pablo Edmundo Antezana
AAAilen Gala Hvozda Arana
Ailen Gala Hvozda Arana
Sofia MunicoySofia Municoy
Sofia Municoy
Martin DesimoneMartin Desimone
Martin Desimone
PEPablo A. Evelson
Pablo A. Evelson
SFSandra Ferrer
Sandra Ferrer
Background/Objectives: Glaucoma is the leading cause of irreversible blindness worldwide and oxidative stress is considered to play a key role in its development. While antioxidants offer a promising approach to mitigating oxidative stress, their clinical application is often hindered by bioavailability and absorption challenges. Entrapment antioxidants within liposomes may overcome these issues, enhancing their stability and delivery. The aim of this study was to develop a novel composite liposomal formulation for glaucoma treatment, designed to enhance lipoic acid bioavailability and administration through its incorporation into the lipid bilayer. Methods: Liposomes were prepared via lipid film hydration and extrusion. To characterize them, the following analyses were performed: FTIR spectroscopy, liposomal bilayer melting temperature (Tm), TEM, DLS, Z-potential, antioxidant activity, and cytotoxicity assays. Results: The efficient incorporation of lipoic acid into the liposomes’ lipid bilayer was confirmed by FTIR. This incorporation resulted in an increase in the Tm, from 37.0 °C for liposomes to 40.0 °C for liposomes with lipoic acid (L-LA). TEM images confirmed that the spherical morphology of the lipid vesicles remained unchanged following LA incorporation. Dynamic Light Scattering analysis revealed effective diameters of 423 ± 36 nm for L liposomes and 404 ± 62 nm for L-LA liposomes. Notably, the Z-potential shifted from +4.7 ± 0.4 mV (L) to −0.4 ± 0.3 mV (L-LA). Furthermore, L-LA exhibited significant antioxidant activity (31.6 ± 0.4%) compared with L (5.3 ± 0.3%) and biocompatibility, suggesting its potential for therapeutic applications. Conclusions: In summary, biocompatible composite liposomes with antioxidant capacity were successfully developed, resulting in promising candidates for neuroprotective glaucoma therapy.